Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies

L Pimpin, H Cortez-Pinto, F Negro, E Corbould… - Journal of …, 2018 - Elsevier
The burden of liver disease in Europe continues to grow. We aimed to describe the
epidemiology of liver diseases and their risk factors in European countries, identifying public …

HLA variation and disease

CA Dendrou, J Petersen, J Rossjohn… - Nature Reviews …, 2018 - nature.com
Fifty years since the first description of an association between HLA and human disease,
HLA molecules have proven to be central to physiology, protective immunity and …

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

RP Payne, S Longet, JA Austin, DT Skelly… - Cell, 2021 - cell.com
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was
introduced in the United Kingdom to accelerate population coverage with a single dose. At …

[PDF][PDF] Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD

JM Paik, P Golabi, Y Younossi, A Mishra… - …, 2020 - Wiley Online Library
Background and Aims Chronic hepatitis B virus (HBV), hepatitis C virus (HCV), nonalcoholic
fatty liver disease (NAFLD), and alcohol‐associated liver disease (ALD) are main causes of …

From hepatitis A to E: A critical review of viral hepatitis

D Castaneda, AJ Gonzalez, M Alomari… - World journal of …, 2021 - pmc.ncbi.nlm.nih.gov
Viral infections affecting the liver have had an important impact on humanity, as they have
led to significant morbidity and mortality in patients with acute and chronic infections. Once …

[HTML][HTML] Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non …

PM Folegatti, M Bittaye, A Flaxman… - The Lancet Infectious …, 2020 - thelancet.com
Summary Background Cases of Middle East respiratory syndrome coronavirus (MERS-CoV)
infection continue to rise in the Arabian Peninsula 7 years after it was first described in Saudi …

Getting to HBV cure: The promising paths forward

S Fung, HSJ Choi, A Gehring, HLA Janssen - Hepatology, 2022 - Wiley Online Library
Chronic HBV infection is a global public health burden estimated to impact nearly 300
million persons worldwide. Despite the advent of potent antiviral agents that effectively …

[HTML][HTML] Approaches, progress, and challenges to hepatitis C vaccine development

JR Bailey, E Barnes, AL Cox - Gastroenterology, 2019 - Elsevier
Risk factors for hepatitis C virus (HCV) infection vary, and there were an estimated 1.75
million new cases worldwide in 2015. The World Health Organization aims for a 90 …

Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejection

AM D'Alise, N Brasu, C De Intinis, G Leoni… - Science translational …, 2022 - science.org
Upon chronic antigen exposure, CD8+ T cells become exhausted, acquiring a dysfunctional
state correlated with the inability to control infection or tumor progression. In contrast, stem …

CD39 Expression Identifies Terminally Exhausted CD8+ T Cells

PK Gupta, J Godec, D Wolski, E Adland, K Yates… - PLoS …, 2015 - journals.plos.org
Exhausted T cells express multiple co-inhibitory molecules that impair their function and limit
immunity to chronic viral infection. Defining novel markers of exhaustion is important both for …